Remarkably, an increase in the expression of the CHRNβ2 neuronal gene in HeLa cells was observed, which has been widely reported as a transcriptional target of REST and could be included in the panel of cervical cancer prognostic biomarkers. The gene discussed is CHRNB2; the disease is cervical carcinoma.